Roots Analysis Information

At Roots Analysis, we are recognized as domain experts in pharma, biotech, and healthcare, while also extending our research expertise into semiconductors, ICT, and chemicals. Since 2013, we’ve helped 𝟏,𝟓𝟎𝟎+ 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐥𝐢𝐞𝐧𝐭𝐬, from startups to 𝐅𝐨𝐫𝐭𝐮𝐧𝐞 𝟓𝟎𝟎𝐬, turn complex data into clear, strategic actions. 𝐖𝐡𝐚𝐭 𝐦𝐚𝐤𝐞𝐬 𝐮𝐬 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 We combine sector-agnostic intelligence with vertical-specialized frameworks, enabling you to benchmark clinical and commercial pharma trends, while also assessing adjacent domains. Our network spans 450,000+ senior stakeholders, with a strong foundation in life sciences and pharma, complemented by reach across ICT, electronics, and chemicals / materials. Our range of proprietary models cover drug delivery, clinical development, emerging therapeutic modalities, and market access. Whether you’re evaluating a novel drug delivery platform, assessing opportunities in emerging therapies, or analyzing venture trends in telehealth, our reports and consulting engagements are built to power strategic decisions that drive growth, investment, and innovation. We focus on delivering what’s actionable. From predicting edge-AI-driven demand in telecom modules to mapping sustainability pathways in specialty chemicals, our clients trust us to clarify complexity and frame opportunity. Follow us for 𝐩𝐡𝐚𝐫𝐦𝐚/𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 to stay ahead. And as industries converge, you can also benefit from our insights in 𝐬𝐞𝐦𝐢𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 & 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲, 𝐜𝐡𝐞𝐦𝐢𝐜𝐚𝐥𝐬/𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬.